RxDoctor Payments Data

Craig Recko, MD

Family Medicine · Vermilion, OHNPI 1578783486

Payments from drug & device makers

$6,650in general payments, 2019–2025

Across 465 payments — averaging $14.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$765
  • Pfizer$709
  • Boehringer Ingelheim$428
  • Amgen$408
  • Novo Nordisk$310
  • plus $3K from 34 others

What the payments were for

  • Food & beverage$6,61399%
  • Education$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,650 in reported general payments places this provider in the 90th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$101,126
Medicare patients
414
Services billed
10,349

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate97$125,524
OtezlaApremilast23$111,359
XareltoRivaroxaban82$81,631
EliquisApixaban75$74,978
OzempicSemaglutide56$72,980
TrulicityDulaglutide35$70,390
MounjaroTirzepatide39$49,504
RybelsusSemaglutide40$45,839
FarxigaDapagliflozin Propanediol33$38,473
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$27,811
JardianceEmpagliflozin29$25,804
Combivent RespimatIpratropium/Albuterol Sulfate37$23,879
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$16,161
ViberziEluxadoline11$15,958
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog17$14,195

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$172$125,52497 claims
Lilly USA, LLCTrulicity, Mounjaro$175$119,89474 claims
Novo NordiskOzempic, Rybelsus$310$118,81996 claims
AmgenOtezla$408$111,35923 claims
Johnson & JohnsonXarelto$276$81,63182 claims
PfizerEliquis$709$74,97875 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$105$49,69559 claims
Boehringer IngelheimJardiance, Combivent Respimat$428$49,68266 claims
AstraZenecaFarxiga, Symbicort$765$44,33046 claims
AbbVieViberzi, Linzess$1,079$23,90924 claims
NovartisEntresto$255$13,74218 claims
Astellas Pharma US IncMyrbetriq$214$12,62618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Vermilion

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →